Key result
Robotics-assisted epicardial left atrial appendage clip exclusion was safe and feasible in 42 patients, with 0% 30-day mortality and no thromboembolic strokes or TIAs at 12 months.
Why the study?
The study was conducted to demonstrate the feasibility and safety of robotics-assisted left atrial appendage clip exclusion in clinical practice.
Is robotics-assisted epicardial left atrial appendage clip exclusion safe and feasible in patients with atrial fibrillation intolerant to oral anticoagulants?
Observational (n=42)
No
Is robotics-assisted epicardial left atrial appendage clip exclusion safe and feasible in patients with atrial fibrillation intolerant to oral anticoagulants?
Robotics-assisted epicardial left atrial appendage clip exclusion appears to be a safe and feasible minimally invasive option for stroke prevention in patients with atrial fibrillation who cannot tolerate oral anticoagulation.
Supports robotic LAA exclusion evaluation in OAC-intolerant AF; leaves open randomized confirmation of safety and efficacy.
OBJECTIVES: We demonstrate the feasibility and safety of robotics-assisted left atrial appendage clip exclusion in clinical practice. METHODS: Analysis of a single center robotics-assisted left atrial appendage clip exclusion experience using an epicardial linear clip device in patients with atrial fibrillation with high-risk of thromboembolic stroke and intolerance to oral anticoagulants. RESULTS: During the period from December 2017 to September 2020, we performed 42 robotics-assisted left atrial appendage clip exclusions in response to increased risk of bleeding in patients with atrial fibrillation and intolerance to oral anticoagulants. The average congestive heart failure, hypertension, age, diabetes, stroke, and vascular disease score was 5.2 ± 1.6 and hypertension, abnormal liver or kidney function, stroke, bleeding, labile international normalized ratio, elderly, drugs (aspirin, other antiplatelets, or anticoagulants) score was 4.5 ± 0.9. No patients died intraoperatively or within 30 days, or due to conversion to thoracotomy, intraoperative complications, or failure to apply the clip satisfactorily. The procedure was successfully completed despite pericardial adhesions in 2 patients with prior coronary bypass grafts and 3 with postpericarditis scars. Intraoperative transesophageal echocardiography was performed in 38 out of 42 patients; satisfactory exclusion with left atrial appendage stump <5 mm was confirmed in all. Average length of stay was 3.4 ± 3 days with 12 out of 42 patients discharged within 24 hours. Oral anticoagulants were discontinued in 41 out of 42 patients and no cases of 30-day stroke, myocardial ischemia, or new arrhythmias were observed. One case of hemothorax required thoracoscopy a day later. There was no reported thromboembolic stroke or transient ischemic attack at 12 months. One case of late lacunar stroke was due to in situ small intracranial vessel thrombosis without left atrial appendage thrombus on imaging. CONCLUSIONS: Robotics-assisted left atrial appendage clip exclusion is a safe and feasible minimally invasive method for left atrial appendage management in patients with atrial fibrillation with intolerance to oral anticoagulants and increased risk of thromboembolic stroke.
No takes yet. Share an insight, caveat, or question.
Antaki et al. (2021) conducted an observational in Atrial fibrillation (n=42). Robotics-assisted epicardial left atrial appendage clip exclusion was evaluated on 30-day mortality and 12-month thromboembolic stroke or transient ischemic attack. Robotics-assisted epicardial left atrial appendage clip exclusion was safe and feasible in 42 patients, with 0% 30-day mortality and no thromboembolic strokes or TIAs at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: